News
ACROSS the UK, waistlines are shrinking – and it’s not down to willpower alone. While Ozempic-like weight-loss jabs have been hailed as a breakthrough in helping tackle Britain’s obesity ...
A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to ...
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...
Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...
Scientists have uncovered a hidden molecule in DNA that helps control fat storage, offering hope for a new kind of obesity treatment.
Scientists have found new evidence that Ozempic can help reverse aging — yet another health benefit added to the laundry list ...
Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...
GLP-1s have been a hot topic, now people are raising concerns about the side effects. From loose skin and dull complexions to hair loss and more. Aesthetic ...
GLP-1 weight-loss drugs are popular but pricey. New data highlights use by age and gender - and why interest outpaces access for many.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results